Neoadjuvant Pembrolizumab plus Chemotherapy Vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab Vs Placebo for Early Tnbc: Surgical Outcomes from the Phase 3 Keynote-522 Study

AuthID
P-00Y-S50
20
Author(s)
Takahashi, M
·
Untch, M
·
Boileau, JF
·
Cortes, J
·
McArthur, H
·
Dent, R
·
O'Shaughnessy, J
·
Pusztai, L
·
Park, YH
·
Hui, RN
·
Cardoso, F
·
Denkert, C
·
Zhu, YL
·
Pan, W
·
Karantza, V
·
Fasching, PA
Document Type
Abstract
Year published
2023
Published
in ANNALS OF SURGICAL ONCOLOGY, ISSN: 1068-9265
Volume: 30, Issue: SUPPL 2, Pages: S295-S296 (2)
Conference
24Th Annual Meeting of The American Society of Breast Surgeons (Asbrs), Date: APR 26-30, 2023, Location: MS
Indexing
Publication Identifiers
Wos: WOS:000999257500012
Source Identifiers
ISSN: 1068-9265
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.